12/20
05:00 pm
iova
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
12/12
10:11 am
iova
Prediction: This Stock Will Beat the Market in 2025 [Yahoo! Finance]
Low
Report
Prediction: This Stock Will Beat the Market in 2025 [Yahoo! Finance]
12/7
11:23 am
iova
3 Monster Stocks to Hold for the Next 10 Years [Yahoo! Finance]
Low
Report
3 Monster Stocks to Hold for the Next 10 Years [Yahoo! Finance]
12/3
05:59 am
iova
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63% [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63% [Yahoo! Finance]
11/27
06:47 am
iova
Is Iovance Biotherapeutics Stock a Millionaire Maker? [Yahoo! Finance]
Low
Report
Is Iovance Biotherapeutics Stock a Millionaire Maker? [Yahoo! Finance]
11/26
04:14 pm
iova
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer [Yahoo! Finance]
11/26
04:01 pm
iova
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
Medium
Report
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
11/23
11:46 am
iova
Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back [Yahoo! Finance]
Medium
Report
Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back [Yahoo! Finance]
11/23
10:41 am
iova
Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds [Yahoo! Finance]
11/22
10:09 am
iova
2 Innovative Stocks That Could Deliver Outsize Returns [Yahoo! Finance]
Low
Report
2 Innovative Stocks That Could Deliver Outsize Returns [Yahoo! Finance]
11/12
02:11 pm
iova
Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/9
08:53 am
iova
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
11/8
08:19 am
iova
Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ... [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ... [Yahoo! Finance]
11/7
07:48 pm
iova
Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/7
04:18 pm
iova
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024 [Yahoo! Finance]
Low
Report
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024 [Yahoo! Finance]
11/7
04:08 pm
iova
Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M [Seeking Alpha]
Low
Report
Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M [Seeking Alpha]
11/7
04:01 pm
iova
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
High
Report
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
11/6
08:07 am
iova
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Low
Report
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
10/31
04:01 pm
iova
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
Medium
Report
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
10/24
06:17 pm
iova
Why Iovance Biotherapeutics Stock Triumphed on Thursday [Yahoo! Finance]
Low
Report
Why Iovance Biotherapeutics Stock Triumphed on Thursday [Yahoo! Finance]
10/24
07:16 am
iova
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $17.00 price target on the stock.
Medium
Report
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $17.00 price target on the stock.
10/16
07:24 pm
iova
Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts? [Yahoo! Finance]
Medium
Report
Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts? [Yahoo! Finance]